Clinical Trials Browser

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT07398170 2026-02-09

BIOLIMEN-1

Phase NA Not yet recruiting

15 enrolled

CNS

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

NCT07198945 2026-02-04

STARLING

Phase NA Not yet recruiting

546 enrolled

Gastrointestinal

Adenoma, Colonic Neoplasms, Colonic Polyps, Neoplasm Recurrence, Local, Recurrence

NCT03583619 2026-01-26

Randomized Trial of Accelerated Partial Breast Irradiation

Phase NA Completed

140 enrolled

Breast

Breast Neoplasms, Neoplasm Recurrence, Local

NCT03583580 2026-01-12

Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer

Phase NA Active not recruiting

537 enrolled

Breast

Breast Neoplasms, Neoplasm Recurrence, Local

NCT06912087 2025-12-02

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

Phase 1 Recruiting

36 enrolled

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Phase 2 Recruiting

36 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

NCT01299987 2025-03-30

TARGIT-E

Phase NA Completed

591 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Recurrence, Local, Neoplasms

Clinical Trials

IPAX BrIGHT

BIOLIMEN-1

STARLING

Randomized Trial of Accelerated Partial Breast Irradiation

Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

TARGIT-E